Correlation Between CohBar and InMed Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both CohBar and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CohBar and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CohBar Inc and InMed Pharmaceuticals, you can compare the effects of market volatilities on CohBar and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CohBar with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CohBar and InMed Pharmaceuticals.

Diversification Opportunities for CohBar and InMed Pharmaceuticals

0.23

Correlation Coefficient

CohBar  InMed Pharmaceuticals

Modest diversification

The 3 months correlation between CohBar and InMed is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding CohBar Inc and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and CohBar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CohBar Inc are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of CohBar i.e., CohBar and InMed Pharmaceuticals go up and down completely randomly.

Pair Corralation between CohBar and InMed Pharmaceuticals

Given the investment horizon of 90 days CohBar Inc is expected to generate 1.84 times more return on investment than InMed Pharmaceuticals. However, CohBar is 1.84 times more volatile than InMed Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest  219.00  in CohBar Inc on September 16, 2024 and sell it today you would earn a total of  80.00  from holding CohBar Inc or generate 36.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	26.21%
Values	Daily Returns

CohBar Inc  vs.  InMed Pharmaceuticals

CohBar Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CohBar Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, CohBar is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

InMed Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in InMed Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, InMed Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CohBar and InMed Pharmaceuticals

The main advantage of trading using opposite CohBar and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CohBar position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.

The idea behind CohBar Inc and InMed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.